Direxion Daily South Korea Bull 3X Shares (KORU) 옵션

There's no reason to believe that the FDA has given its final feedback on the PD trial design.

I trust they’ll get it done.

We don’t need another study, they’ve done enough to be granted MAA approval.

“Based on the content of the article and standard practices for JAMA Oncology, the reviewers likely had access to:
Manuscript Details:
Study Design: The article describes a nonrandomized contro

...

I have always believed this, someone within Delfin's organization doesn't want OTC traders on this trade. Take the information below for what it's worth. I truly believe they are still keeping this under wraps, because if Jones was listed as the CEO and business description was Delfin's, that woul

Will never forget my 3 milly of ENZ*. Bought at triple zero. Sold at .13 went it started to drop. Thought I did well. Bought spouse a new car....but then it goes off to .91🤬. Could have bought a nice home and two cars. Yes there are scams and diamonds in hiding

Ron Filipkowski's favorite signs from yesterday's protest
https://www.meidasplus.com/p/top-signs-at-hands-off-protests-42025

https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2F

You left this one out:
SAN DIEGO, CALIFORNIA, Sept. 16, 2022 (GLOBE NEWSWIRE) -- HUMBL, Inc. (“HUMBL”) (OTC Markets: HMBL) has announced it has terminated the Securities Exchange Agreement previously announced on August 11, 2022 for HUMBL to acquire Ecoark’s approximately 89% owned subsidiar

Ft. Worth yesterday 
https://vt.tiktok.com/ZSrstyN42/

(cont) Another aspect is what happens when the broader finance oligarchy (UK / Europe) decide that the current US dollar centric system has had it, and is no longer viable? They see the end coming, so instead of riding a dying horse into the ground, they prepare to transition to a new system. The

Are you not bashing people as well?

When Otiko can't keep a simple promise to post Financials by a certain date, how are we to believe anything he puts forth in a PR?

More stupid is 7 years of thinking people are bashing a non existent company.

I believe the 1 billion addition to the OS is just showing the 1 billion to Canouse that was already reported on.

Everyone always thinks penny stock mullets will hold their shares and die believing they were duped (you were but never by who you think).
Why, on every penny board do people make the same exact claims, but always think their situation is different?

I could see that presentation getting an Oscar……

from WretchWatch Magazine.

One day and a whole hour.

Congrats longs!

That hard work is really starting to pay off.

Broken record.

JD gets Holy Ghosted ,

Pope Ghosts JD Vance at Vatican, Sends Top Cardinal to Lecture VP on Compassion
https://www.europesays.com/2009702/

Vice President JD Vance flew to Rome hoping to meet with Pope Francis. Instead, the Pope skipped the meeting entirely—and se

What a small world, I recognize on occasion posters from DBMM and other plays I've been in.

Congratulations to anyone who makes a living trading pinkies can't be easy, If I were trading pinkies for a living my thinking would be to drop about $100.000 bucks on 20 to 30 pinkies set sell

Its a deferred comp package which will be reported in 1st quarter. Plus that guy has got skin like asphalt. He hardly reacts and mostly laughs when I tell him the posts. Its like brushing lint off your shoulder he says. Meaningleess and unnsubstatiated babble.

you're lying. prove it.

$TWOH has the management team involved in the recent $NUKK deal:
Emil Assentato, Craig Marshak and Matthew Stark

WOW, now VPLM has turned into a “gamble” and is no longer an investment…..???

YEP, PRETTY MUCH!

“So, because the defendants haven’t settled, they feel they can crush the RICO???

YEP, PRETTY MUCH!.

“The premise here, suggesting there would

JAMA is all we need to prove DCvax-L’s effectiveness at treating GBM.
I guarantee you the JAMA paper is not sufficient for approval.

Even the second tier RAs like MHRA will insist on the full dataset, something not in the JAMA paper and was not seen by the reviewers.